ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $22,615,401 | -3.2% | 2,960,131 | -9.7% | 0.30% | -10.4% |
| Q3 2022 | $23,351,000 | -18.4% | 3,279,620 | -7.3% | 0.34% | -17.3% |
| Q2 2022 | $28,631,000 | -34.4% | 3,539,055 | +12.5% | 0.40% | -20.1% |
| Q1 2022 | $43,657,000 | -21.0% | 3,145,293 | +59.8% | 0.51% | -10.9% |
| Q4 2021 | $55,234,000 | +21.6% | 1,968,431 | +47.3% | 0.57% | +23.4% |
| Q3 2021 | $45,411,000 | +15.5% | 1,336,023 | +38.8% | 0.46% | +20.1% |
| Q2 2021 | $39,322,000 | – | 962,352 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |